ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : TUMOUR MODELS
Australian State/Territory : ACT
Field of Research : Cellular Immunology
Clear All
Filter by Field of Research
Cellular Immunology (3)
Biochemistry and Cell Biology not elsewhere classified (1)
Humoural Immunology and Immunochemistry (1)
Immunology (1)
Tumour Immunology (1)
Filter by Socio-Economic Objective
Cancer and Related Disorders (1)
Immune System and Allergy (1)
Filter by Funding Provider
National Health and Medical Research Council (2)
Australian Research Council (1)
Filter by Status
Closed (3)
Filter by Scheme
Discovery Projects (1)
Program Grants (1)
Project Grants (1)
Filter by Country
Australia (3)
Filter by Australian State/Territory
ACT (3)
VIC (1)
  • Researchers (2)
  • Funded Activities (3)
  • Organisations (2)
  • Funded Activity

    Modeling Human Actin Related Protein 2/3 Complex Subunit 1B (ARPC1B) Deficiency In Mice

    Funder
    National Health and Medical Research Council
    Funding Amount
    $755,005.00
    Summary
    The actin cytoskeleton forms the structure that not only keeps cells in their normal shape but is also essential for the movement of cells and for interaction between cells. We have recently identified the first patients with an immunodeficiency caused by a defect in a gene called ARPC1B, which plays a crucial role in the regulation of actin. Through the investigation of novel mouse models we will elucidate the pathomechanism underlying the disease of these patients.
    More information
    Funded Activity

    Uncovering The Basis Of Inflammatory And Immunodeficiency Diseases

    Funder
    National Health and Medical Research Council
    Funding Amount
    $15,718,075.00
    Summary
    A world-class team from 3 institutions, spanning disciplines of clinical and experimental immunology, therapeutics, signalling and genetics, will identify how immune and inflammatory responses are controlled in both health and disease. The major outcomes of this work will be the generation of new knowledge, concepts and approaches to diagnose, prevent and treat the major human health problems of autoimmune diseases, inflammation, allergy and immunodeficiency.
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP110105024

    Funder
    Australian Research Council
    Funding Amount
    $315,000.00
    Summary
    microRNAs and the control of T lymphocyte differentiation, function and malignant transformation. The molecular mechanism of the immune system is not completely understood. This project will investigate how transcription factors and microRNAs, two major types of regulatory molecules work together to control immune responses. The results from this research will assist in the design of better vaccination strategies and treat certain lymphomas.
    More information

    Showing 1-3 of 3 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback